The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide, was previously ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

Health News // 6 days ago FDA says shortage of GLP-1 drug tirzepatide is over The U.S. Food and Drug Administration reissued ...

Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...

Taxi jumps curb, slams into Christmas Day crowd outside Manhattan Macy’s on W. 34th St. A taxi cab jumped the curb and slammed into six pedestrians walking near Macy's on W. 34th St. and Sixth ...

Wexford’s Linda Kelly and Katie-George Dunlevy crowned RTÉ Sport Team of the Year – ‘For a para-athlete to win something like this, it’s huge’ ...

A driver involved in a tragic hit-and-run incident in Phuket turned himself into the police. Police confirmed that the driver will face charges for his actions following the fatal accident that ...